von Tobias Borgers | Sep 6, 2021 | Bayer
Bayer Middle East has introduced its Alleye Home Monitoring Sponsorship Programme to the Egyptian healthcare sector, it has been confirmed. The global pharma giant is reportedly working with some of the country’s top-rated eye hospitals to “support Egypt’s...
von Tobias Borgers | Aug 29, 2021 | Bayer
Bayer’s history in China dates back more than a century. Bayer Bayer has business locations in 83 countries around the world. Overall, pharmaceuticals are its second-biggest business after crop science, accounting for 41.6% of sales of about 17 billion...
von Tobias Borgers | Aug 29, 2021 | Bayer
Bayer bolsters its drug discovery capabilities through the acquisition of Vividion, which it says will benefit from an arm’s length business model. The deal – which could be worth up to $2 billion – strengthens Bayer’s small molecule oncology and immunology targets...
von Tobias Borgers | Aug 10, 2021 | Bayer
Berlin, 5. August 2021 – Die Bayer AG hat Vividion Therapeutics, Inc. (Vividion), ein biopharmazeutisches Unternehmen mit Hauptsitz in den USA, das durch neue Forschungstechnologien einen hohen Mehrwert erzielt, erworben. So kann Vividion traditionell nicht...
von Tobias Borgers | Jul 31, 2021 | Bayer
Enko, a crop health company, has announced details on its partnership with Bayer to develop diverse chemistries for crop protection. Applying drug discovery approaches from pharma to crop protection will allow the companies to identify unexpected product candidates...
von Tobias Borgers | Jul 10, 2021 | Bayer
Über BayerBayer ist ein weltweit tätiges Unternehmen mit Kernkompetenzen auf den Life-Science-Gebieten Gesundheit und Ernährung. Mit seinen Produkten und Dienstleistungen will das Unternehmen Menschen nützen und die Umwelt schonen, indem es zur Lösung grundlegender...
